Our data effectively exhibit the severe gemcitabine chemoresistance in HyPer-low CCA cells with high expression of MTHFD1 but neglect to verify the potential possibility that HyPer-low CCA cells have equal CCA stem cells, which should be completed in our future study. The gene discussed is MTHFD1; the disease is cholangiocarcinoma.